NCT03480815View on ClinicalTrials.gov

Nocturnal TLA for Severe Allergic Asthma After Withdrawal of Omalizumab Therapy

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 20, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

June 30, 2020

Conditions
Severe Allergic Asthma
Interventions
DEVICE

Nocturnal Temperature Controlled Laminar Flow Device

Record of the time to first asthma exacerbation, lung function and exhaled NO level

OTHER

None Device

Record of the time to first asthma exacerbation, lung function and exhaled NO level

Trial Locations (1)

Unknown

Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT03480815 - Nocturnal TLA for Severe Allergic Asthma After Withdrawal of Omalizumab Therapy | Biotech Hunter | Biotech Hunter